CV
CapsoVision, Inc
Key Financials
Operating Income
$-25516000
↓ 28.1%
Revenue
$13.6M
↑ 15.3%
Gross Profit
$7.2M
↑ 12.5%
Net Income
$-25315000
↓ 27.2%
Total Assets
$18.2M
↑ 8.1%
EPS (Diluted)
$-1.03
↑ 89.5%
Shareholders' Equity
$13.3M
↑ 110.2%
Total Liabilities
$4.9M
↑ 82.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/28/2026 | View on SEC |
| 4 | 9/23/2026 | View on SEC |
| 4/A | 9/23/2026 | View on SEC |
| 4/A | 9/23/2026 | View on SEC |
| 4 | 9/18/2026 | View on SEC |
| 8-K | 9/18/2026 | View on SEC |
| 424B5 | 9/18/2026 | View on SEC |
| EFFECT | 8/21/2026 | View on SEC |
| 424B5 | 8/21/2026 | View on SEC |
| 8-K | 8/18/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CV |
| Company Name | CapsoVision, Inc |
| CIK | 1378325 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (408) 370-4790 |